Trials / Completed
CompletedNCT00631033
DZX Mediated Insulin Suppression in Obese Men
Diazoxide-mediated Insulin Suppression in Hyperinsulinemic Obese Men, Part III
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Rijnstate Hospital · Academic / Other
- Sex
- Male
- Age
- 25 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether there is an additive effect of metformine on the weight reduction of obese hyperinsulinemic men who are treated with diazoxide.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | |
| DRUG | Diazoxide | |
| DRUG | Metformin + Diazoxide |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2008-03-07
- Last updated
- 2014-11-06
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00631033. Inclusion in this directory is not an endorsement.